Uex EBIT per Share
Delisted
The EBIT per Share of Uex (UEX.TO) as of Aug 13, 2026 is -0.01 CAD. In the previous year, EBIT per Share was -0.01 CAD — a change of 7.09% (lower).
Get this data via API
Financial Data API
EBIT per Share
-0.01CAD
YoY
7.09%
Last updated:
EBIT per Share of Uex is 2026 -0.01 CAD. EBIT per Share of Uex was 2025 -0.01 CAD. It decreases by 7.09% lower compared to the previous year.
Access this data via the Eulerpool API
Uex Stock analysis
What does Uex do? Uex Corp is an innovative technology company based in New York City, specializing in providing innovative and groundbreaking solutions for various industries and clients around the world. The company was founded in 1997 by entrepreneur and CEO Jack Uex and has since become one of the leading companies in the technology industry.
The history of Uex Corp began with the goal of harnessing the potential of neuroscience and connecting human brain activity with computer-assisted systems. The company has expanded its research and development in the field of neuroscience to create innovative technologies that enhance human senses, improve brain performance, and enhance communication. These technologies have broad applications in medicine, research, gaming, entertainment, and education.
Uex Corp's business model is based on providing innovative solutions for various industries and clients. The company has four pillars that encompass its activities: Healthcare, Gaming, Education, and Research. Uex Corp specializes in developing products and services for these areas, focusing on improving life and creating new avenues for human potential.
In the healthcare sector, Uex Corp offers innovative solutions for medical diagnosis and treatment. The products include neuroscientific technologies for cognitive rehabilitation, pain therapy, and the treatment of neurological disorders. Uex Corp's integrated systems enable patients to better control their recovery and track their progress. The products are used by renowned hospitals and healthcare facilities worldwide.
In the gaming sector, Uex Corp offers interactive games and entertainment systems developed based on neuroscience and human-computer interaction. The games promote cognitive development and mental health and provide an alternative experience based on brain-computer interaction.
In the education sector, Uex Corp develops interactive teaching and learning systems based on neuroscience. These systems allow students to improve their cognitive abilities through playful learning. The teaching and learning systems can be used in schools, universities, and other institutions.
The research sector of Uex Corp is an important part and core competency of the company. Uex Corp continuously works on researching neuroscientific technologies and related systems. The company collaborates closely with renowned research institutions and universities to integrate the latest developments and insights into research and development.
Uex Corp offers a wide range of technologies and systems based on the company's research and development areas. These products include brain-computer interfaces, neurofeedback systems, biofeedback devices, and intelligent spatial systems. Uex Corp's products are capable of enhancing users' cognitive abilities by measuring and analyzing the electrical signals of the brain in real-time.
In summary, Uex Corp is an innovative technology company specializing in the development of neuroscientific technologies and systems. With a broad product portfolio based on its core competencies and business areas, Uex Corp offers groundbreaking solutions for various industries and clients around the world. Uex is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Uex stock
EBIT per Share of Uex is -0.01 CAD in 2026.
EBIT per Share of Uex changed from -0.01 CAD to -0.01 CAD, representing a 7.09% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Uex since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Uex
All Key Metrics — Uex
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth